Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT04050787Not ApplicableUnknown

Spleen-Preserving No. 10 Lymph Node Dissection in Gastric Cancer

Role: lead

NCT01979029Not ApplicableCompleted

Study of the Preservation of the Left Colic Artery on Rectum Cancer Surgery

Role: lead

NCT01910948Phase 4Unknown

Perioperative Application of Omega-3 Polyunsaturated Fatty Acids in Gastric Cancer Patients

Role: lead

All 3 trials loaded